NASDAQ:DOXAmdocs Stock Price, Forecast & News

Amdocs' stock was trading at $61.42 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, DOX stock has increased by 3.8% and is now trading at $63.74. View which stocks have been most impacted by Coronavirus.

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Amdocs in the last year. There are currently 2 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Amdocs.

Amdocs is scheduled to release its next quarterly earnings announcement on Wednesday, August 5th 2020. View our earnings forecast for Amdocs.

Amdocs Limited (NASDAQ:DOX) issued its quarterly earnings results on Thursday, May, 7th. The technology company reported $1.08 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $1.06 by $0.02. The technology company earned $1.05 billion during the quarter, compared to the consensus estimate of $1.04 billion. Amdocs had a net margin of 11.98% and a return on equity of 16.03%. The firm's revenue was up 2.8% compared to the same quarter last year. During the same period in the previous year, the business earned $1.06 EPS. View Amdocs' earnings history.

Amdocs announced a quarterly dividend on Thursday, May 7th. Investors of record on Tuesday, June 30th will be given a dividend of $0.327 per share on Friday, July 24th. This represents a $1.31 annualized dividend and a yield of 2.05%. The ex-dividend date is Monday, June 29th. View Amdocs' dividend history.

Amdocs issued an update on its third quarter earnings guidance on Thursday, May, 7th. The company provided earnings per share (EPS) guidance of $1.00 to $1.08 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $1.16. The company issued revenue guidance of $990 million to $1.040 billion, compared to the consensus revenue estimate of $1.05 billion.

5 analysts have issued 12-month target prices for Amdocs' stock. Their forecasts range from $72.00 to $85.00. On average, they anticipate Amdocs' share price to reach $76.40 in the next year. This suggests a possible upside of 19.9% from the stock's current price. View analysts' price targets for Amdocs.

News stories about DOX stock have trended neutral on Thursday, according to InfoTrie. The research group identifies positive and negative news coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Amdocs earned a news sentiment score of 0.4 on InfoTrie's scale. They also assigned media headlines about the technology company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the company's share price in the next few days. View the latest news aboutAmdocs.

Amdocs saw a increase in short interest in the month of May. As of May 15th, there was short interest totaling 2,700,000 shares, an increase of 5.1% from the April 30th total of 2,570,000 shares. Based on an average daily trading volume, of 1,090,000 shares, the short-interest ratio is currently 2.5 days. Approximately 2.0% of the shares of the company are sold short. View Amdocs' Current Options Chain.

Some companies that are related to Amdocs include Accenture (ACN), IBM (IBM), Cognizant Technology Solutions (CTSH), Leidos (LDOS), EPAM Systems (EPAM), Gartner (IT), Booz Allen Hamilton (BAH), Caci International (CACI), Mantech International (MANT), Teradata (TDC), Virtusa (VRTU), Unisys (UIS), Forrester Research (FORR), The Hackett Group (HCKT) and Servicesource International (SREV). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Amdocs investors own include AbbVie (ABBV), Comcast (CMCSA), AT&T (T), Walt Disney (DIS), Gilead Sciences (GILD), Home Depot (HD), Intel (INTC), Pfizer (PFE), Verizon Communications (VZ) and Cisco Systems (CSCO).

Amdocs trades on the NASDAQ under the ticker symbol "DOX."

Amdocs' stock is owned by a number of institutional and retail investors. Top institutional shareholders include Janus Henderson Group PLC (5.10%), Wellington Management Group LLP (4.90%), Wells Fargo & Company MN (4.69%), BlackRock Inc. (3.33%), Massachusetts Financial Services Co. MA (3.22%) and Invesco Ltd. (2.90%).

DOX stock was sold by a variety of institutional investors in the last quarter, including Bessemer Group Inc., Janus Henderson Group PLC, AJO LP, Morgan Stanley, Morgan Stanley, Citigroup Inc., Wells Fargo & Company MN, and New South Capital Management Inc..

DOX stock was purchased by a variety of institutional investors in the last quarter, including First Trust Advisors LP, NWQ Investment Management Company LLC, Invesco Ltd., Wellington Management Group LLP, Harel Insurance Investments & Financial Services Ltd., Acadian Asset Management LLC, Robeco Institutional Asset Management B.V., and Schroder Investment Management Group.

Shares of DOX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of DOX stock can currently be purchased for approximately $63.74.

Amdocs has a market capitalization of $8.59 billion and generates $4.09 billion in revenue each year. The technology company earns $479.45 million in net income (profit) each year or $4.07 on an earnings per share basis. Amdocs employs 24,516 workers across the globe.

The official website for Amdocs is www.amdocs.com.

Amdocs' mailing address is 1390 Timberlake Manor Parkway, Chesterfield MO, 63017. The technology company can be reached via phone at 1 314 212 7000 or via email at [email protected]